Evidence map›Paper›PMID 35019968›Full record

ArticleThe American journal of occupational therapy : official publication of the American Occupational Therapy Association2022

Measuring Value: Cost-Effectiveness Analysis for Occupational Therapy.

Corey Morrow, Kit Simpson

Abstract read
In one paragraph

Article in The American journal of occupational therapy : official publication of the American Occupational Therapy Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Health Services Research and Occupational Therapy: Ensuring Quality and Cost-Effectiveness.The American journal of occupational therapy : official publication of the American Occupational Therapy Association · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Corey MorrowCorey Morrow, MOT, OTR/L, is PhD Candidate, Department of Health Sciences and Research, College of Health Professions, Medical University of South Carolina, Charleston; morrowco@musc.edu.
Kit SimpsonKit Simpson, DrPH, is Distinguished Professor, Department of Healthcare Leadership and Management, College of Health Professions, Medical University of South Carolina, Charleston.

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR001451 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FEGHALI-BOSTWICK, CAROL A. · 2015 to 2024
$4.6M
Medical University of South CarolinaNCATS NIH HHS TL1 TR001451NCATS NIH HHS UL1 TR001450South Carolina Clinical and Translational Research Institute, Medical University of South Carolina
6 · The paper itself

Abstract

Stroke rehabilitation is expensive, and recent changes to Medicare reimbursement demand more efficient interventions. The use of cost-effectiveness analysis (CEA) can help occupational therapy practitioners, rehabilitation directors, and payers better understand the value of occupational therapy and decide whether or not to implement new treatments. The objective of this article is to illustrate the contribution of CEA to stroke rehabilitation using a hypothetical new intervention as an example. What This Article Adds: This article facilitates an understanding of the importance of CEA to occupational therapy. It also explains how CEA improves consistency with reporting standards for cost-effectiveness studies.

Indexed as

Occupational TherapyStrokeStroke RehabilitationAgedCost-Benefit AnalysisHumansMedicareUnited States

Identifiers

PMID35019968
PMCPMC8865575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.